Characteristics of neurovegetative disorders in ischemic heart disease patients after coronavirus disease 2019 (COVID-19)
DOI:
https://doi.org/10.14739/2310-1210.2024.2.297015Keywords:
coronary heart disease, anxiety, depression, cognitive impairment, heart rate variability, autonomic dysfunction, relationshipAbstract
The aim of the study. To examine the frequency and spectrum of cognitive, anxiety-depressive, autonomic disorders and their interrelationship in patients with coronary heart disease (CHD) after COVID-19 infection.
Materials and methods. The study involved 71 patients with CHD, stable angina pectoris FC II–III (age 69.0 [64.0; 76.0] years): group 1 (main) – 31 CHD patients after COVID-19; group 2 (comparison) – 40 CHD patients without COVID-19 history. Spectral and temporal HRV parameters were assessed using 24-hour Holter ECG monitoring, anxiety-depressive disorders (ADD) – using the HADS scale, cognitive status of patients – according to the MoCa scale.
Results. CHD patients after COVID-19 had a higher frequency of ADD detection and a greater anxiety level (16 [10; 24] versus 10 [9; 13] points, p < 0.05), depression (14 [8; 20] versus 11 [10; 12] points, p < 0.05) as compared to patients without previous history of COVID-19. At the same time, the predominance of the anxiety component over the depressive one in patients of both groups has been revealed. In CHD patients after COVID-19, a decrease in the total MoCa scale score has been found as compared to patients without COVID-19: 24 [22; 26] versus 28 [26; 30] points, p < 0.05. There was an association between the total level of anxiety and depression and the severity of cognitive impairment (r = -0.36, p < 0.05). CHD patients exposed to COVID-19 showed an increased sympathetic and parasympathetic tone of the central nervous system within 24 hours, an increased LF/HF ratio during the active period, activation of slow-acting humoral regulation mechanisms amid increasing stress index and centralization index. In the group of patients with CHD after COVID-19, a wide range of correlations between the rate of ADD, cognitive disorders and HRV parameters has been found.
Conclusions. Patients with coronary heart disease recovered from COVID-19 have shown an increase in the incidence and degree of ADD and cognitive disorder manifestations which was accompanied by autonomic dysfunction resulting in stress on the functional and adaptive state of the cardiovascular system. The association between ADD, autonomic and cognitive disorders in patients with coronary heart disease after COVID-19 has confirmed the common pathogenetic links of the disorders found.
References
Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-37. doi: https://doi.org/10.1093/eurheartj/ehab484
Mostovoi YM, Rasputina LV, Didenko DV, Dovhan AO. [Ventricular rhythm disturbances during computer spirography in patients with stable ischemic heart disease and chronic obstructive pulmonary disease: clinical and functional predictors of occurrence]. Zaporozhye medical journal. 2019;21(3):308-13. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2019.3.169008
Fedorov SV. [Ischemic heart disease is the main cause of mortality in patients with cardiovascular diseases]. Liky Ukrainy. 2022;(2):15-7. Ukrainian. doi: https://doi.org/10.37987/1997-9894.2022.2(258).264086
Sirenko YM. [The state of the problem of cardiovascular morbidity and mortality in Ukraine]. Liky Ukrainy. 2022;(2):11-4. Ukrainian. doi: https://doi.org/10.37987/1997-9894.2022.2(258).264084
Cherkaskyi VV, Riabokon OV, Riabokon YY. Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19). Pathologia. 2023;19(3):214-20. doi: https://doi.org/10.14739/2310-1237.2022.3.266544
Shishkin A, Lhewa P, Yang C, Gankin Y, Chowell G, Norris M, et al. Excess mortality in Ukraine during the course of COVID-19 pandemic in 2020-2021. Sci Rep. 2023;13(1):6917. doi: https://doi.org/10.1038/s41598-023-33113-2
Shrestha AB, Mehta A, Pokharel P, Mishra A, Adhikari L, Shrestha S, et al. Long COVID Syndrome and Cardiovascular Manifestations: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2023;13(3):491. doi: https://doi.org/10.3390/diagnostics13030491
Mahase E. Long covid could be four different syndromes, review suggests. BMJ. 2020;371:m3981. doi: https://doi.org/10.1136/bmj.m3981
Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):57. doi: https://doi.org/10.1186/s12992-020-00589-w
Vannorsdall TD, Brigham E, Fawzy A, Raju S, Gorgone A, Pletnikova A, et al. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19. J Acad Consult Liaison Psychiatry. 2022;63(2):133-43. doi: https://doi.org/10.1016/j.jaclp.2021.10.006
Xiong J, Lipsitz O, Nasri F, Lui LM, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55-64. doi: https://doi.org/10.1016/j.jad.2020.08.001
Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-605. doi: https://doi.org/10.1001/jama.2020.12603
Dziak L, Tsurkalenko O, Chekha K, Suk V. [Modern aspects of neuropathogenesis and neurological manifestations of COVID-19]. Mizhnarodnyi nevrolohichnyi zhurnal. 2021;17(2):6-15. Ukrainian. doi: https://doi.org/10.22141/2224-0713.17.2.2021.229887
Alqahtani MS, Abbas M, Alshahrani MY, Alabdullh K, Alqarni A, Alqahtani FF, et al. Effects of COVID-19 on Synaptic and Neuronal Degeneration. Brain Sci. 2023;13(1):131. doi: https://doi.org/10.3390/brainsci13010131
Sattar Y, Ullah W, Rauf H, Virk HU, Yadav S, Chowdhury M, et al. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. Int J Cardiol Heart Vasc. 2020;29:100589. doi: https://doi.org/10.1016/j.ijcha.2020.100589
Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S, Hajdarević A, Kudić N, et al. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol Biomed. 2023;23(1):37-52. doi: https://doi.org/10.17305/bjbms.2022.7762
Kopchak O. [Features of cognitive disorders in COVID-19]. Mizhnarodnyi nevrolohichnyi zhurnal. 2021;17(3):12-7. Ukrainian. doi: https://doi.org/10.22141/2224-0713.17.3.2021.231569
Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. doi: https://doi.org/10.1371/journal.pone.0246590
Mykhailovska NS, Stetsiuk IO. Vegetative and electrical disorders in women with chronic coronary syndrome depending on the state of bone mineral density. Pathologia. 2022;19(2):98-103. doi: https://doi.org/10.14739/2310-1237.2022.2.254816
Reis Carneiro D, Rocha I, Habek M, Helbok R, Sellner J, Struhal W, et al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection - A systematic review. Eur J Neurol. 2023;30(5):1528-39. doi: https://doi.org/10.1111/ene.15714
Jammoul M, Naddour J, Madi A, Reslan MA, Hatoum F, Zeineddine J, et al. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton Neurosci. 2023;245:103071. doi: https://doi.org/10.1016/j.autneu.2022.103071
Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A, Yus M, Gómez-Ruiz N, Jorquera M, et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40-6. doi: https://doi.org/10.1016/j.jpsychires.2022.03.033
Barrantes FJ. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses. ACS Chem Neurosci. 2020;11(18):2793-803. doi: https://doi.org/10.1021/acschemneuro.0c00434
Singh S, Meher N, Mohammed A, Razab MK, Bhaskar LV, Nawi NM. Neurological infection and complications of SARS-CoV-2: A review. Medicine (Baltimore). 2023;102(5):e30284. doi: https://doi.org/10.1097/MD.0000000000030284
Lundstrom K, Hromić-Jahjefendić A, Bilajac E, Aljabali AA, Baralić K, Sabri NA, et al. COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity. Cell Signal. 2023;101:110495. doi: https://doi.org/10.1016/j.cellsig.2022.110495
Fang SC, Wu YL, Tsai PS. Heart Rate Variability and Risk of All-Cause Death and Cardiovascular Events in Patients With Cardiovascular Disease: A Meta-Analysis of Cohort Studies. Biol Res Nurs. 2020;22(1):45-56. doi: https://doi.org/10.1177/1099800419877442
Hohls JK, Beer K, Arolt V, Haverkamp W, Kuhlmann SL, Martus P, et al. Association between heart-focused anxiety, depressive symptoms, health behaviors and healthcare utilization in patients with coronary heart disease. J Psychosom Res. 2020;131:109958. doi: https://doi.org/10.1016/j.jpsychores.2020.109958
Wu M, Shen L, Wang Q, Liu L, Lu S, Jin J, et al. Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China. Front Public Health. 2022;9:758874. doi: https://doi.org/10.3389/fpubh.2021.758874
Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother. 2021;135:111200. doi: https://doi.org/10.1016/j.biopha.2020.111200
Vinkers CH, van Amelsvoort T, Bisson JI, Branchi I, Cryan JF, Domschke K, et al. Stress resilience during the coronavirus pandemic. Eur Neuropsychopharmacol. 2020;35:12-6. doi: https://doi.org/10.1016/j.euroneuro.2020.05.003
Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235-40. doi: https://doi.org/10.1038/s41386-021-00978-8
Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg Health West Pac. 2023;38:100836. doi: https://doi.org/10.1016/j.lanwpc.2023.100836
Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, et al. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39-48. doi: https://doi.org/10.1016/j.euroneuro.2021.03.019
Acanfora D, Nolano M, Acanfora C, Colella C, Provitera V, Caporaso G, et al. Impaired Vagal Activity in Long-COVID-19 Patients. Viruses. 2022;14(5):1035. doi: https://doi.org/10.3390/v14051035
Netiazhenko VZ, Mostovyi SE, Safonova OM. [The impact of COVID-19 upon intracardiac hemodynamics and heart rate variability in stable coronary artery disease patients]. Ukrainskyi zhurnal sertsevo-sudynnoi khirurhii. 2023;31(1):19-28. Ukrainian. doi: https://doi.org/10.30702/ujcvs/23.31(01)/nm009-1928
Singla S, Jhamb S, Singh KD, Kumar A. Depression affects autonomic system of the body? Yes, it does! J Educ Health Promot. 2020;9:217. doi: https://doi.org/10.4103/jehp.jehp_627_19
Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-7. doi: https://doi.org/10.7861/clinmed.2020-0896
Svitailo VS, Chemych MD, Sayenko OS. [Long-COVID and associated injuries of the cardiovascular and nervous systems]. Infektsiyni khvoroby. 2023;(4):49-54. Ukrainian. doi: https://doi.org/10.11603/1681-2727.2022.4.13701
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
